BoomerangFX Partners with DrFirst to Launch E-Prescribing for Aesthetic Medicine Practices Across North America
Retrieved on:
Thursday, June 8, 2023
Software as a service, Partnership, Electronic prescribing, EMR, Ground substance, Woman, Prescription, Pharmacy, Sale, Dermatology, EPCS, Acquisition, Patient, Charting, Physician, Investment, Practice management, CRM, Artificial intelligence, United Kingdom, Growth, Stripe, Research, Health, Nursing, Pharmaceutical industry, Medical device
Research suggests that aesthetic medicine is experiencing an explosion in consumer adoption and is proving to be increasingly recession resilient.
Key Points:
- Research suggests that aesthetic medicine is experiencing an explosion in consumer adoption and is proving to be increasingly recession resilient.
- Cosmetic surgeons and physicians from a variety of disciplines are benefiting from the increased demand for facial and body enhancement procedures utilizing minimally invasive procedures.
- "We are thrilled to incorporate DrFirst's medication management solutions into our industry-leading practice management platform," said Jerome Dwight, CEO and co-founder of BoomerangFX.
- "We are pleased to partner with BoomerangFX," said G. Cameron Deemer, CEO of DrFirst.